[Br:1][C:2]1[CH:15]=[C:14]2[C:9]([CH:10]=[CH:11][N:12]([C@H:17]3[CH2:22][CH2:21]C[CH2:19][C@@H:18]3[OH:23])[C:13]2=[O:16])=[C:8]2[C:3]=1[CH:4]=[CH:5][CH:6]=[N:7]2.N[C@H]1CCCC[C@@H]1[OH:31]>>[Br:1][C:2]1[CH:15]=[C:14]2[C:9]([CH:10]=[CH:11][N:12]([C@@H:17]3[C@@H:18]([OH:23])[CH2:19][O:31][CH2:21][CH2:22]3)[C:13]2=[O:16])=[C:8]2[C:3]=1[CH:4]=[CH:5][CH:6]=[N:7]21,5-Anhydro-3-(5-bromo-7-oxo-1,8-phenanthrolin-8(7H)-yl)-2,3-dideoxy-L-threo-pentitol was prepared by the procedure described for the synthesis of 5-bromo-8-[(1S,2S)-2-hydroxycyclohexyl]-1,8-phenanthrolin-7(8H)-one in Example 1, substituting (3R,4S)-4-aminotetrahydro-2H-pyran-3-ol for (1S,2S)-2-aminocyclohexanol.